Higher levels of circulating insulin may promote cancer development by affecting insulin-like growth factor-binding proteins and by increasing IGF1 bioactivity, which has proliferative, angiogenic, antiapoptotic, and estrogen-stimulating properties [28]. The gene discussed is INS; the disease is cancer.